Tri Chemical Laboratories (FRA:22E) ROE %: 20.25% (As of Apr. 2026) — 10% Below Median


FRA:22E Tri Chemical Laboratories Inc FRA:22E
97 GF Score
Price €18.70
GF Value €26.92
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Tri Chemical Laboratories ROE %?

Tri Chemical Laboratories FRA:22E -4.10% 97 ROE % is 20.25% as of Apr. 2026, which is 10% below its 10-year median of 22.38. GuruFocus rates FRA:22E with a GF Score™ of 97/100 and a GF Value™ of €26.92 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 1,586 Chemicals companies, Tri Chemical Laboratories ranks better than 90.42% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Tri Chemical Laboratories's annualized net income for the quarter that ended in Apr. 2026 was €39.9 Mil. Tri Chemical Laboratories's average Total Stockholders Equity over the quarter that ended in Apr. 2026 was €197.0 Mil. Therefore, Tri Chemical Laboratories's annualized ROE % for the quarter that ended in Apr. 2026 was 20.25%.

The historical rank and industry rank for Tri Chemical Laboratories's ROE % or its related term are showing as below:

FRA:22E' s ROE % Range Over the Past 10 Years
Min: 9.25   Med: 22.38   Max: 37.43
Current: 17.91

During the past 13 years, Tri Chemical Laboratories's highest ROE % was 37.43%. The lowest was 9.25%. And the median was 22.38%.

FRA:22E's ROE % is ranked better than
90.42% of 1586 companies
in the Chemicals industry
Industry Median: 5.185 vs FRA:22E: 17.91

Tri Chemical Laboratories  (FRA:22E) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Apr. 2026 )
=Net Income/Total Stockholders Equity
=39.88/196.958
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(39.88 / 160.96)*(160.96 / 255.1525)*(255.1525 / 196.958)
=Net Margin %*Asset Turnover*Equity Multiplier
=24.78 %*0.6308*1.2955
=ROA %*Equity Multiplier
=15.63 %*1.2955
=20.25 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Apr. 2026 )
=Net Income/Total Stockholders Equity
=39.88/196.958
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (39.88 / 53.42) * (53.42 / 44.472) * (44.472 / 160.96) * (160.96 / 255.1525) * (255.1525 / 196.958)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.7465 * 1.2012 * 27.63 % * 0.6308 * 1.2955
=20.25 %

Note: The net income data used here is four times the quarterly (Apr. 2026) net income data. The Revenue data used here is four times the quarterly (Apr. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Tri Chemical Laboratories ROE % Related Terms


Tri Chemical Laboratories ROE % Historical Data

* Premium members only.

The historical data trend for Tri Chemical Laboratories's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tri Chemical Laboratories ROE % Chart

Tri Chemical Laboratories Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.90 19.74 8.68 16.65 15.31

Tri Chemical Laboratories Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.36 18.88 14.50 16.55 20.25

FRA:22E vs LIN, SHW, ECL: ROE % Comparison

For the Specialty Chemicals subindustry, Tri Chemical Laboratories's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tri Chemical Laboratories ROE % vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Tri Chemical Laboratories's ROE % distribution charts can be found below:

* The bar in red indicates where Tri Chemical Laboratories's ROE % falls into.


FRA:22E
97GF Score
Tri Chemical Laboratories Inc FRA:22E
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tri Chemical Laboratories ROE % Calculation

Tri Chemical Laboratories's annualized ROE % for the fiscal year that ended in Jan. 2026 is calculated as

ROE %=Net Income (A: Jan. 2026 )/( (Total Stockholders Equity (A: Jan. 2025 )+Total Stockholders Equity (A: Jan. 2026 ))/ count )
=29.961/( (194.998+196.382)/ 2 )
=29.961/195.69
=15.31 %

Tri Chemical Laboratories's annualized ROE % for the quarter that ended in Apr. 2026 is calculated as

ROE %=Net Income (Q: Apr. 2026 )/( (Total Stockholders Equity (Q: Jan. 2026 )+Total Stockholders Equity (Q: Apr. 2026 ))/ count )
=39.88/( (196.382+197.534)/ 2 )
=39.88/196.958
=20.25 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Apr. 2026) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 20.25% mean?
Tri Chemical Laboratories (FRA:22E) has a ROE % of 20.25% as of Apr. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Tri Chemical Laboratories and its competitors. This is 10% below median its historical median of 22.38. Over the past decade, Tri Chemical Laboratories' ROE % has ranged from 9.25 to 37.43. According to the industry distribution chart, Tri Chemical Laboratories ranks #152 out of 1586 companies in the Chemicals industry, placing it in the top 9.6%.
Is Tri Chemical Laboratories' ROE % too high?
Tri Chemical Laboratories' current ROE % of 20.25% is 10% below median its 10-year median of 22.38. Over the past 10 years, this metric has ranged from a low of 9.25 to a high of 37.43. The Chemicals industry median ROE % is 5.19. Tri Chemical Laboratories' value of 20.25% is 290.5% above this industry median. Based on the distribution chart, Tri Chemical Laboratories ranks #152 out of 1586 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Tri Chemical Laboratories has a GF Score™ of 97/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tri Chemical Laboratories' ROE % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Tri Chemical Laboratories ranks #152 out of 1586 companies for ROE %. This places Tri Chemical Laboratories in the top 10% of its industry — outperforming the majority of peers. The industry median ROE % is 5.19. Tri Chemical Laboratories' value of 20.25% is 290.5% above this benchmark. Historically, Tri Chemical Laboratories' own ROE % has ranged from 9.25 to 37.43 over the past decade. While the company's 10-year median is 22.38 vs. the industry median of 5.19, Tri Chemical Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Chemicals company?
The median ROE % among Chemicals companies is 5.19, based on 1,586 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tri Chemical Laboratories's current ROE % of 20.25% is 290.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Tri Chemical Laboratories and its competitors. For the Chemicals industry, the median ROE % is 5.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tri Chemical Laboratories's current ROE % is 20.25%, which is 10% below median its own 10-year median of 22.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tri Chemical Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Tri Chemical Laboratories (FRA:22E) is currently considered Modestly Undervalued. The stock's GF Value™ is €26.92, compared to a current price of €18.70 — trading 30.5% below its estimated fair value. The current ROE % is 20.25%, which is 10% below median its 10-year median of 22.38 and 290.5% above the Chemicals industry median of 5.19. Tri Chemical Laboratories' overall GF Score™ is 97/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Tri Chemical Laboratories (FRA:22E), the current ROE % is 20.25% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tri Chemical Laboratories (FRA:22E) Overvalued in 2026?

Based on GuruFocus' analysis, Tri Chemical Laboratories stock appears to be undervalued. The current stock price of €18.70 is trading 30.5% below its estimated GF Value™ of €26.92. GuruFocus considers Tri Chemical Laboratories to be Modestly Undervalued.

Key valuation signals for FRA:22E:

  • ROE %: 20.25% (10% below median its 10-year median of 22.38)
  • GF Value™: €26.92 vs. price of €18.70 (30.5% below fair value)
  • GF Score™: 97/100 with 2 warning signs
  • Industry Position: 290.5% above the Chemicals median (#152 of 1586)

No single metric tells the full story. See the FRA:22E stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Tri Chemical Laboratories Business Description

Other Exchanges 4369:Japan
Address 8154-217 Uenohara, Uenohara-shi, Yamanashi, JPN, 409-0112
Tri Chemical Laboratories Inc is engaged in the manufacturing of high-purity chemical compounds for the semiconductor industry.
97GF Score

Get the complete analysis for FRA:22E

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€18.70
Price
€26.92
GF Value